Disappointing earnings sent the markets tumbling to a sharply lower open with the Dow plunging 102 points to 20,534. Nasdaq fell 17 points to 5,839.
On the upside
UnitedHealthcare will cover Interspace Diagnostics Group's (Nasdaq: IDXG) ThyraMIR to assess indeterminate thyroid nodule fine needle aspirate biopsies.
GNC Holdings (NYSE: GNC) reported better than expected earnings for the first quarter.
Synovus Financial (NYSE: SNV) will acquire the assets and liabilities of Cabela's (NYSE: CAB) wholly owned subsidiary World's Foremost Bank.
On the downside
Arena Pharmaceuticals (Nasdaq: ARNA) priced its public offering of 60 million common shares at the discounted price of $1.15 per share.
Cardinal Health (NYSE: CAH) will pay approximately $6.1 billion to acquire certain Patient Monitoring & Recovery businesses from Medtronic (NYSE: MDT).
Investors locked in profits on Cleveland BioLabs (Nasdaq: CBLI).
In the broad market, declining issues outpaced advancers by a margin of more than 7 to 5 on the NYSE and by 2 to 1 on Nasdaq. The broader S&P 500 index fell 7 points to 2,341. Bitcoin leaped $20 to $1209.